| Keyword | CPC | PCC | Volume | Score | Length of keyword |
|---|---|---|---|---|---|
| adar1 inhibitor | 0.43 | 0.9 | 6323 | 85 | 15 |
| adar1 | 0.3 | 0.3 | 7170 | 5 | 5 |
| inhibitor | 0.93 | 0.8 | 2411 | 65 | 9 |
| Keyword | CPC | PCC | Volume | Score |
|---|---|---|---|---|
| adar1 inhibitor | 1.47 | 0.1 | 3016 | 35 |
| adar1 inhibitor clinical trial | 0.66 | 0.7 | 7819 | 8 |
| adar1 inhibitor small molecule | 1.24 | 0.8 | 7488 | 69 |
| ddr1 inhibitor clinical trial | 1.76 | 0.4 | 9304 | 55 |
| anti-adar1 role in cancer | 0.73 | 0.6 | 1370 | 46 |
| anti-adar1 mechanism of action | 1.63 | 0.8 | 6460 | 23 |
| rad51 inhibitor clinical trial | 1.12 | 0.3 | 7803 | 82 |
| anti adar1 polyclonal antibody | 0.23 | 0.3 | 5558 | 74 |
| atr inhibitor clinical trial | 0.38 | 0.5 | 9896 | 61 |
| adar1 affect gene expression | 0.69 | 0.9 | 5994 | 14 |
| ccr2 inhibitor clinical trial | 1.48 | 0.2 | 5965 | 65 |
| a2a inhibitor clinical trial | 1.57 | 0.3 | 1833 | 72 |
| rac1 inhibitor clinical trial | 1.17 | 0.5 | 4066 | 40 |
| adar1 masks the cancer immunotherapeutic | 0.79 | 0.8 | 7094 | 64 |
| adar1 co-immunoprecipitation | 0.89 | 0.4 | 9917 | 94 |
| substrate recognition by adar1 and adar2 | 1.22 | 0.4 | 542 | 61 |
| what is adar ii | 0.44 | 1 | 1504 | 74 |
| adar1 r-loop | 0.52 | 0.3 | 354 | 5 |
| adar 1 and adar 2 | 1.02 | 0.6 | 34 | 24 |
| adar1-dsrna-mda5 | 0.64 | 0.9 | 3637 | 24 |
| adar1-p150 | 1.69 | 0.6 | 1393 | 11 |
